Recurrence of borderline ovarian tumors

Recurrence of borderline ovarian tumors

Aim - to increase the efficiency of diagnosis and treatment of patients with recurrences of borderline ovarian tumors (BOT). 106 patients with BOT of stage I have been treated and clinically observed: the I group (82 patients, mean age - 38,9 +- 5,5 years), who were treated with standard surgical op...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Datum:	2013
Hauptverfasser:	Svintsitskiy, V.S., Vorobyova, L.I., Klymenko, E.S., Dermenzhy, T.V., Tkalya, J.G.
Format:	Artikel
Sprache:	English
Veröffentlicht:	Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2013
Schriftenreihe:	Experimental Oncology
Schlagworte:	Original contributions
Online Zugang:	http://dspace.nbuv.gov.ua/handle/123456789/145204
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:	Recurrence of borderline ovarian tumors / V.S. Svintsitskiy, L.I. Vorobyova, E.S. Klymenko, T.V. Dermenzhy, J.G. Tkalya // Experimental Oncology. — 2013. — Т. 35, № 2. — С. 118-121. — Бібліогр.: 17 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Ähnliche Einträge

Clinical significance of hormonal receptor status of malignant ovarian tumors
von: Tkalia, I.G., et al.
Veröffentlicht: (2014)

Recurrence of borderline ovarian tumors
von: V. S. Svintsitskiy, et al.
Veröffentlicht: (2013)

Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
von: Tkalia, I.G., et al.
Veröffentlicht: (2014)

The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats
von: Tkalia, I.G., et al.
Veröffentlicht: (2015)

Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
von: Kryzhanivska, A.E., et al.
Veröffentlicht: (2018)

Quantitative analysis of SLC34A2 expression in different types of ovarian tumors
von: Shyian, M., et al.
Veröffentlicht: (2011)

Survivin expression in ovarian cancer
von: Liguang, Z., et al.
Veröffentlicht: (2007)

Expression OF p53, p21WAF1/CIP1 , p16INK4A and Ki-67 proteins in serous ovarian tumors
von: Buchynska, L.G., et al.
Veröffentlicht: (2007)

Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers
von: Buchynska, L.G., et al.
Veröffentlicht: (2009)

Effects of alvocidib and carboplatin on ovarian cancer cells in vitro
von: Baumann, K.H., et al.
Veröffentlicht: (2013)

Comparison of various tissue and cell therapy approaches when restoring ovarian, hepatic and kidney’s function after chemotherapy-induced ovarian failure
von: Kozub, M.M., et al.
Veröffentlicht: (2017)

Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
von: Ryabtseva, O.D., et al.
Veröffentlicht: (2013)

Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats
von: Chekhun, V.F., et al.
Veröffentlicht: (2018)

Expression of cancer-associated genes in prostate tumors
von: Rosenberg, E.E., et al.
Veröffentlicht: (2017)

Nanohyperthermia of malignant tumors. II. In vivo tumor heating with manganese perovskite nanoparticles
von: Bubnovskaya, L., et al.
Veröffentlicht: (2012)

Cloning of variable fragments of tumor immunoglobulin, assembling and expressing of human SCFV protein in E. coli for anti-idiotype vaccination
von: Meleshko, A.N., et al.
Veröffentlicht: (2013)

The study of phosphate transporter NaPi2b expression in different histological types of epithelial ovarian cancer
von: Gryshkova, V., et al.
Veröffentlicht: (2009)

Nanohyperthermia of malignant tumors.i. lanthanum-strontium manganite magnetic fluid as potential inducer of tumor hyperthermia
von: Solopan, S., et al.
Veröffentlicht: (2011)

Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

In VIVO anti-tumor activities of gelatin
von: Inamura, Y., et al.
Veröffentlicht: (2009)

Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
von: Bereznaya, N.M., et al.
Veröffentlicht: (2008)

The frequency of human papilloma virus types 16, 18 in upper genital tract of women at high risk of developing ovarian cancer
von: Bilyk, O.O., et al.
Veröffentlicht: (2014)

Cytogenetic effects of neutron therapy in patients with parotid gland tumors and relapse of breast cancer
von: Melnikov, A.A., et al.
Veröffentlicht: (2012)

Establishment and characterization of new breast and ovarian cancer cell lines as a model for studying cellular plasticity in vitro
von: Bezdieniezhnykh, N., et al.
Veröffentlicht: (2016)

The long-range cytotoxic effect in tumor-bearing animals
von: Gerashchenko, B.I., et al.
Veröffentlicht: (2012)

Phenotypic features of endometrial tumors in patients with family history of cancer
von: Buchynska, L.G., et al.
Veröffentlicht: (2017)

Aspisol inhibits tumor growth and induces apoptosis in breast cancer
von: Zhu, X.G., et al.
Veröffentlicht: (2008)

Expression of steroid and peptide hormone receptors, metabolic enzymes and EMT-related genes in prostate tumors in relation to the presence of the TMPRSS2/ERG fusion
von: Gerashchenko, G.V., et al.
Veröffentlicht: (2018)

Analysis of P53, P16INK4A, PRB and cyclin D1 expression and human papillomavirus in primary ovarian serous carcinoma
von: Bilyk, O.O., et al.
Veröffentlicht: (2011)

Influence of two pt(iv) complexes on viability, apoptosis and cell cycle of B16 mouse melanoma tumors
von: Kaznica, A., et al.
Veröffentlicht: (2009)

Immunohistochemical analysis of beta-defensin-2 expression in human lung tumors
von: Shestakova, T., et al.
Veröffentlicht: (2010)

Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs
von: Yurchenko, O.V., et al.
Veröffentlicht: (2010)

Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
von: Lukyanova, N.Yu.
Veröffentlicht: (2010)

Regulatory T cells but not NKT I cells are modulated by a single low-dose Cyclophosphamide in a B cell lymphoma tumor-model
von: Rico, M.J., et al.
Veröffentlicht: (2012)

Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer
von: Lurchenko, N.P., et al.
Veröffentlicht: (2014)

Influence of doxorubicin inclusion into phospholipid nanoformulation on its antitumor activity in mice: increased efficiency for resistant tumor model
von: Zykova, M.G., et al.
Veröffentlicht: (2012)

Age-related function of tumor suppressor gene TP53:contribution to cancer risk and progression
von: Cherdyntseva, N.V., et al.
Veröffentlicht: (2010)

Effects of combined sonodynamic and photodynamic therapies with photolon on a glioma C6 tumor model
von: Tserkovsky, D.A., et al.
Veröffentlicht: (2012)

Efficacy of natural L-asparagine in the complex therapy for malignant tumors in experimental studies
von: Urazova, L.N., et al.
Veröffentlicht: (2011)

DNA damage in tumor cells and peripheral blood lymphocytes of endometrial cancer patients assessed by the comet assay
von: Buchynska, L.G., et al.
Veröffentlicht: (2017)